A new biotech company has raised $25 million to finance research on the effects of psychedelics and other drugs on depression and other mental illnesses.
Plant and Drug Research Studies
A new biotech company has raised $25 million to finance research on the effects of psychedelics and other drugs on depression and other mental illnesses.
Internet valium abuse a growing problem in Galway city, says mayor The Irish Times
Children as young as 13 buying drugs illegally online, says Niall McNelis.
Psychedelic Mushrooms Are Closer to Medicinal Use (It’s Not Just Your Imagination) The New York Times
Researchers from Johns Hopkins University have recommended that psilocybin, the active compound in hallucinogenic mushrooms, be reclassified for medical …
Researchers Want Doctors to Be Able to Prescribe Magic Mushrooms for Depression Motherboard
A new study out of Johns Hopkins University seeks to reclassify psilocybin mushrooms since they have low potential for abuse and few risks of dependence.
Is CBD healthy? Big Think
For the first time in nearly a half-century, the federal government has approved a medication with a cannabis compound. DEA PR officer says this could signal a …
The DEA is finally changing how it regulates marijuana products Big Think
For the first time in nearly a half-century, the federal government has approved a medication with a cannabis compound. DEA PR officer says this could signal a …